Commentary

The Rise of Prostate Cancer Genetic Testing

By

Jody A. Charnow

Publish Date August 7, 2020

Use of PCa genetic testing to stratify risk and guide screening and management continues to gain momentum.

Expanding Options for Kidney Failure Patients

By

Natasha Persaud

Publish Date July 13, 2020

Gradual transition to dialysis and palliative dialysis should be alternatives offered to patients with advanced chronic kidney disease, according to an editorial.

Race ‘Correction’ in Clinical Algorithms Needs Re-examination

By

Natasha Persaud

Publish Date June 18, 2020

Clinicians should consider whether a race correction will relieve or exacerbate inequities, according to editorialists.

The COVID-19 Pandemic Proves the World Is Small

By

Jody Charnow

Publish Date June 11, 2020

The rapid spread of coronavirus disease 2019 (COVID- 19) caught the world by surprise. Whatever becomes the new normal, the United States will be a different country from what it was on March 13, when President Donald J. Trump declared a national emergency. At this writing on May 28, more than 100,000 people in the…

Ode to Burton ‘Bud’ Rose, MD

By

Anthony J. Bleyer, MD

Publish Date May 19, 2020

Like many of my colleagues, I was very saddened to hear of the passing of Dr Burton “Bud” Rose on April 24, 2020 at the age of 77 years. There were two important sides of Dr Rose:  First, he was well known in the nephrology community as an extremely modest, brilliant nephrologist who published 2…

Twice-Weekly Hemodialysis Is Gaining Acceptance

By

Kamyar Kalantar-Zadeh, MD, PhD, MPH

Publish Date February 5, 2020

Back in August 2012, I wrote a provocative editorial in this space titled, “How About Twice-Weekly Hemodialysis?” This was the first time the topic of dialysis provided less frequently than 3 times a week was brought up in the 21st century. I argued that because kidney function worsens gradually, dialysis treatment should be gradual and…

Basic Science: The Tail That Wags the RCC Dog

By

Robert Uzzo, MD, MBA, FACS

Publish Date November 22, 2019

I recently had reason to survey the progress made in renal cell cancer (RCC) over the last 70 or more years. In 1950, a patient who presented with metastatic RCC had a 0%-5% overall response rate (ORR) to the therapies of the time, with an anticipated overall survival (OS) of approximately 10 months. By 2005,…

Kidney Health Initiative Offers Promise, Unknowns

By

Kamyar Kalantar-Zadeh, MD, PhD, MPH

Publish Date October 3, 2019

Many nephrologists and other healthcare providers (HCPs) have enthusiastically embraced the July 10 presidential executive order titled, “Advancing American Kidney Health Initiative.” The 3 main components include a reduction in the end-stage renal disease (ESRD) rate by 25% by 2030; a substantial increase in home dialysis so that 80% of new ESRD patients can receive…

Fighting a Silent Killer: Identifying Chronic Kidney Disease at Stage 1

By

Mandeep Sahani, MD

Publish Date September 17, 2019

The benefits of early diagnosis of chronic kidney disease (CKD) are significant, as patients in whom CKD is diagnosed in the early stages have the chance to make lifestyle changes, learn how to manage their disease, and extend their lives while avoiding or postponing the need for dialysis or transplant.

RCC in Advanced CKD: A Transplant Dilemma

By

Robert Uzzo, MD, MBA, FACS

Publish Date July 15, 2019

Non-dialysis patients with advanced CKD diagnosed with renal malignancies grapple with the dual threat of renal failure and cancer progression. When  choosing between functional or oncologic risks, many patients will ask about renal transplantation. Discussions of  this option are complicated by statistical realities: According to UNOS, of  nearly 1 million solid organ transplants performed over…